Close
Nordic 9Nordic 9

Eisbach (private company)

Germany eisbach.bio
See something wrong or missing? Let us know
Offices:Munich
Industry:BiotechHealth servicesManufacturingPharma
Business model:B2B

Eisbach Bio is a biotechnology startup in Germany that creates new drugs that target molecular vulnerabilities in cancer genomes.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 4.5M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Eisbach

Name Criteria
Germany Biomes
62%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Finland FinnAdvance
62%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Finland Uute Scientific Oy
62%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Spain ViveBiotech
62%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom CellulaREvolution
62%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Denmark ResoTher Pharma
62%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
France SmartCatch
62%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Poland Molecule.one
62%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
62%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Sweden Nanolyze
62%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Top